Veryan Medical

Core Business and Scientific Focus

Veryan Medical's primary business revolves around its intellectual property and expertise in designing stent systems that leverage the principles of haemodynamics, specifically swirling blood flow.

The Link to Haemodynamics

The company?s technology is based on pioneering research by Professor Colin Caro, which established a link between vessel geometry, blood flow mechanics, and vascular disease. Traditional, straight arterial stents can create areas of low wall shear stress (WSS), which is a key factor in the development of atherosclerosis and restenosis (re-narrowing of the artery after treatment).

Veryan Medical's innovation is the use of a three-dimensional (3D) helical geometry in its stents. This unique design is intended to impart a gentle, helical shape to the stented artery, which in turn provokes a swirling (non-planar) blood flow. This swirling flow is nature's way of protecting vessel patency, as it raises the wall shear stress (WSS) along the artery wall, a mechanism shown to reduce the formation of intimal hyperplasia (the primary cause of restenosis) and improve long-term clinical outcomes.

Products and Services Offered

Veryan Medical is a product-centric organization, with its main offering being a unique vascular stent system designed for treating PAD. The company?s services are primarily in the areas of regulatory compliance, clinical development, and global distribution support for its device.

1. BioMimics 3D? Vascular Stent System (Product)

The BioMimics 3D? Vascular Stent System is the company's flagship and core product. It is a peripheral, self-expanding stent indicated for improving luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the superficial femoral and/or proximal popliteal arteries. These are particularly challenging arteries due to the biomechanical forces they experience, especially during leg movement (flexion and extension of the knee).

• Technology and Design:
  • Material: It is a self-expanding stent laser cut from a straight nitinol (nickel-titanium alloy) tube, where the unique 3D helical shape is stored in the nitinol's shape memory.
  • Mechanism of Action: The imparted helical shape generates a protective swirling flow, which increases wall shear stress to mitigate intimal hyperplasia.
  • Biomechanical Compatibility: The helical design allows the stented femoropopliteal vessel to shorten more naturally during knee and hip flexion. This distributes compressive strain across the entire stent, offering excellent fracture resistance and reduced vascular injury compared to straight stents, which localize the strain at specific points.
• Delivery System: The stent is delivered via a co-axial, over-the-wire (OTW) delivery system with a 6-French shaft profile. The system incorporates radiopaque markers to aid precise placement during the minimally invasive endovascular procedure.
• Clinical Evidence: The device's safety and effectiveness are supported by an evolving database of clinical studies, most notably the MIMICS Clinical Programme (including the MIMICS-3D European Registry), which has demonstrated satisfying outcomes comparable to those of drug-eluting stents in challenging lesion characteristics.

2. Global Distribution and Support (Service)

As a global medical device manufacturer, Veryan Medical is responsible for:

• Manufacturing and Quality Assurance: Ensuring the BioMimics 3D stent is manufactured to the highest international quality standards, maintaining essential regulatory clearances such as the CE Mark (European approval) and FDA approval (United States approval).
• Clinical and Scientific Support: Managing the ongoing clinical research program (MIMICS) to continuously generate data on the long-term safety and effectiveness of the stent, providing physicians with comprehensive technical and clinical information.
• Commercial Distribution: Working with a network of international distributors across Europe, the Middle East, Asia, and other regions to ensure the product is available to clinicians treating patients with PAD. The company provides all necessary ordering information and customer service support for its global partners and customers. I do not see any backslashes in the output provided above. Please confirm if you are still seeing them. The instruction in your "Saved Information" is:

Always use markdown characters and do not escape them.

The three previous outputs followed this instruction by using the literal markdown formatting characters (like ** for bolding and ## for headings) inside the code block without escaping them with backslashes.

If you are seeing any backslashes, they may be an artifact of the viewing environment. However, based on the prompt, I will assume you are referring to the last output and provide it again, ensuring there are absolutely no backslashes () used to escape markdown characters or any other character.

Veryan Medical In-Depth Writeup

Veryan Medical, Ltd. is a specialist medical device company based in the United Kingdom that focuses on the development and commercialization of innovative vascular stent technology. The company operates within the interventional medicine sector, aiming to address the challenges of vascular disease, particularly Peripheral Arterial Disease (PAD). Founded in 2003 as a technology spin-out from Imperial College, London, Veryan Medical's core philosophy is rooted in biomimicry and the physiological mechanics of blood flow. In 2018, the company became part of the Otsuka Medical Devices group, a member of the global Otsuka total healthcare company.

Core Business and Scientific Focus

Veryan Medical's primary business revolves around its intellectual property and expertise in designing stent systems that leverage the principles of haemodynamics, specifically swirling blood flow.

The Link to Haemodynamics

The company?s technology is based on pioneering research by Professor Colin Caro, which established a link between vessel geometry, blood flow mechanics, and vascular disease. Traditional, straight arterial stents can create areas of low wall shear stress (WSS), which is a key factor in the development of atherosclerosis and restenosis (re-narrowing of the artery after treatment).

Veryan Medical's innovation is the use of a three-dimensional (3D) helical geometry in its stents. This unique design is intended to impart a gentle, helical shape to the stented artery, which in turn provokes a swirling (non-planar) blood flow. This swirling flow is nature's way of protecting vessel patency, as it raises the wall shear stress (WSS) along the artery wall, a mechanism shown to reduce the formation of intimal hyperplasia (the primary cause of restenosis) and improve long-term clinical outcomes.

Products and Services Offered

Veryan Medical is a product-centric organization, with its main offering being a unique vascular stent system designed for treating PAD. The company?s services are primarily in the areas of regulatory compliance, clinical development, and global distribution support for its device.

1. BioMimics 3D? Vascular Stent System (Product)

The BioMimics 3D? Vascular Stent System is the company's flagship and core product. It is a peripheral, self-expanding stent indicated for improving luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the superficial femoral and/or proximal popliteal arteries. These are particularly challenging arteries due to the biomechanical forces they experience, especially during leg movement (flexion and extension of the knee).

• Technology and Design:
  • Material: It is a self-expanding stent laser cut from a straight nitinol (nickel-titanium alloy) tube, where the unique 3D helical shape is stored in the nitinol's shape memory.
  • Mechanism of Action: The imparted helical shape generates a protective swirling flow, which increases wall shear stress to mitigate intimal hyperplasia.
  • Biomechanical Compatibility: The helical design allows the stented femoropopliteal vessel to shorten more naturally during knee and hip flexion. This distributes compressive strain across the entire stent, offering excellent fracture resistance and reduced vascular injury compared to straight stents, which localize the strain at specific points.
• Delivery System: The stent is delivered via a co-axial, over-the-wire (OTW) delivery system with a 6-French shaft profile. The system incorporates radiopaque markers to aid precise placement during the minimally invasive endovascular procedure.
• Clinical Evidence: The device's safety and effectiveness are supported by an evolving database of clinical studies, most notably the MIMICS Clinical Programme (including the MIMICS-3D European Registry), which has demonstrated satisfying outcomes comparable to those of drug-eluting stents in challenging lesion characteristics.

2. Global Distribution and Support (Service)

As a global medical device manufacturer, Veryan Medical is responsible for:

• Manufacturing and Quality Assurance: Ensuring the BioMimics 3D stent is manufactured to the highest international quality standards, maintaining essential regulatory clearances such as the CE Mark (European approval) and FDA approval (United States approval).
• Clinical and Scientific Support: Managing the ongoing clinical research program (MIMICS) to continuously generate data on the long-term safety and effectiveness of the stent, providing physicians with comprehensive technical and clinical information.
• Commercial Distribution: Working with a network of international distributors across Europe, the Middle East, Asia, and other regions to ensure the product is available to clinicians treating patients with PAD. The company provides all necessary ordering information and customer service support for its global partners and customers.